What should I Know Regarding Pregnancy, Nursing and Administering Levorphanol Tartrate Solution to Children or the Elderly?
If you are PREGNANT
- FDA C (unknown human fetal risk; assess risk/benefit):
If you are NURSING
- Precaution: MOLECULR WT LOW ENOUGH FOR POSSIBLE EXCRETION;LONG TERM NEURO EFFECTS UNKNOWN
If you are an adult over 60
- management or monitoring precaution: General-Consider adding naloxone Rx. Pulmonary-Life threatening respiratory depression risk with high doses, cachexia, or debilitation due to altered pharmacokinetics (poor fat stores, muscle wasting, or altered clearance). Monitor closely at initiation and dose titration. Neuro/Psych-Risk for increased confusion and delirium. May increase fall risk. Avoid treatment with 3 or more CNS active drugs. Gastrointestinal-Constipation risk. Urogenital-Urinary retention risk.
Giving Levorphanol Tartrate Solution to a child under 12
- Severe Precaution: Safety and efficacy not established; pediatric use not recommended by manufacturer. Potential increased sensitivity to effects, adverse CNS effects and respiratory depression. With any opioid, access to naloxone for emergency reversal can mitigate risk from accidental ingestion/overdose.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.